In addition, further in-depth analysis of the effects of different TIMP3 genetic polymorphisms and their mRNA and protein expression levels on tumor progression, biochemical recurrence, and disease prognosis of prostate cancer is required. This evidence concerns the gene TIMP3 and prostate carcinoma.